1980s Publications


  1. Latreille J, Barlogie B, Dosik G, Johnston DA, Drewinko B, Alexanian R. Cellular DNA content as a marker of human multiple myeloma. Blood, 1980 Mar;55(3);403-8. PMID: 7357078
  2. Barlogie B, Latreille J, Freireich EJ, Fu CT, Mellard D, Meistrich M, Andreeff M. Characterization of hematologic malignancies by flow cytometry. Blood Cells, 1980;6(4);719-44. PMID: 7008871


  1. Drewinko B, Alexanian R, Boyer H, Barlogie B, Rubinow SI. The growth fraction of human myeloma cells. Blood, 1981 Feb;57(2);333-8. PMID: 7448427


  1. Barlogie B, Latreille J, Alexanian R, Swartzendruber DE, Smallwood L, Maddox AM, Raber MN, Drewinko B. Quantitative cytology in myeloma research. Clin Haematol, 1982 Feb;11(1);19-46. PMID: 6176382
  2. Latreille J, Barlogie B, Johnston D, Drewinko B, Alexanian R. Ploidy and proliferative characteristics in monoclonal gammopathies. Blood, 1982 Jan;59(1);43-51. PMID: 6172171


  1. Barlogie B, Alexanian R, Gehan EA, Smallwood L, Smith T, Drewinko B. Marrow cytometry and prognosis in myeloma. J Clin Invest, 1983 Sep;72(3);853-61. PMID: 6193144
  2. Grammer LC, Shaughnessy MA, Pruzansky JJ. A solid-phase bead radioimmunoassay for specific IgE to ragweed antigen E. J Immunol Methods, 1983 Mar 11;58(1-2);49-57. PMID: 6339635
  3. Foucar K, Raber M, Foucar E, Barlogie B, Sandler CM, Alexanian R. Anaplastic myeloma with massive extramedullary involvement. Report of two cases. Cancer, 1983 Jan 1;51(1);166-74. PMID: 6336972


  1. Freireich EJ, Keating M, Cabanillas F, Barlogie B. The hematologic malignancies. Leukemia, lymphoma, and myeloma. Cancer, 1984 Dec 1;54(11 Suppl);2741-50. PMID: 6208991
  2. Drewinko B, Mars W, Stragand JJ, Henderson SD, Latreille J, Barlogie B, Trujillo JM. ARH-77, an established human IgG-producing myeloma cell line. II. Growth kinetics, clonogenic capacity, chalone production, xenogeneic transplantations, and response to melphalan. Cancer, 1984 Nov 1;54(9);1893-903. PMID: 6236873
  3. Barlogie B, Smith L, Alexanian R. Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med, 1984 May 24;310(21);1353-6. PMID: 6546971
  4. Epstein JB, Voss NJ, Stevenson-Moore P. Maxillofacial manifestations of multiple myeloma. An unusual case and review of the literature. Oral Surg Oral Med Oral Pathol, 1984 Mar;57(3);267-71. PMID: 6369219
  5. Kantarjian H, Dreicer R, Barlogie B, Plunkett W, Alexanian R. High-dose cytosine arabinoside in multiple myeloma. Eur J Cancer Clin Oncol, 1984 Feb;20(2);227-31. PMID: 6538488


  1. Alexanian R, Barlogie B, Fritsche H. Beta 2 microglobulin in multiple myeloma. Am J Hematol, 1985 Dec;20(4);345-51. PMID: 3907332
  2. Alexanian R, Barlogie B. Multiple myeloma: current management. Tex Med, 1985 Oct;81(10);24-6. PMID: 4060076
  3. Barlogie B, Alexanian R, Dixon D, Smith L, Smallwood L, Delasalle K. Prognostic implications of tumor cell DNA and RNA content in multiple myeloma. Blood, 1985 Aug;66(2);338-41. PMID: 2410065
  4. Barlogie B, Alexanian R, Pershouse M, Smallwood L, Smith L. Cytoplasmic immunoglobulin content in multiple myeloma. J Clin Invest, 1985 Aug;76(2);765-9. PMID: 2411762
  5. Kantarjian HM, Barlogie B, Pershouse M, Swartzendruber D, Keating MJ, McCredie KB, Freireich EJ. Preferential expression of double-stranded ribonucleic acid in tumor versus normal cells: biological and clinical implications. Blood, 1985 Jul;66(1);39-46. PMID: 4005432
  6. McGuire W, Meyer JS, Barlogie B, Kute TE. Impact of flow cytometry on predicting recurrence and survival in breast cancer patients. Breast Cancer Res Treat, 1985;5(2);117-28. PMID: 2410071


  1. Barlogie B, Alexanian R. Therapy of primary resistant and relapsed multiple myeloma. Onkologie, 1986 Aug;9(4);210-4. PMID: 3531948
  2. Alexanian R, Barlogie B, Dixon D. High-dose glucocorticoid treatment of resistant myeloma. Ann Intern Med, 1986 Jul;105(1);8-11. PMID: 3717812
  3. Anaissie E, Kantarjian H, Jones P, Barlogie B, Luna M, Lopez-Berestein G, Bodey GP. Fusarium. A newly recognized fungal pathogen in immunosuppressed patients. Cancer, 1986 Jun 1;57(11);2141-5. PMID: 3457624
  4. Smith L, Barlogie B, Alexanian R. Biclonal and hypodiploid multiple myeloma. Am J Med, 1986 May;80(5);841-3. PMID: 3706371
  5. Barlogie B, Hall R, Zander A, Dicke K, Alexanian R. High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood, 1986 May;67(5);1298-301. PMID: 3516252
  6. Quesada JR, Alexanian R, Hawkins M, Barlogie B, Borden E, Itri L, Gutterman JU. Treatment of multiple myeloma with recombinant alpha-interferon. Blood, 1986 Feb;67(2);275-8. PMID: 3942826


  1. Barlogie B, Alexanian R, Dicke KA, Zagars G, Spitzer G, Jagannath S, Horwitz L. High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood, 1987 Sep;70(3);869-72. PMID: 3304465
  2. Barlogie B, McLaughlin P, Alexanian R. Characterization of hematologic malignancies by flow cytometry. Anal Quant Cytol Histol, 1987 May;9(2);147-55. PMID: 3300685
  3. Alexanian R, Barlogie B. Recent advances in the biology of plasma cell myeloma. Hematol Pathol, 1987;1(3);143-5. PMID: 3334346
  4. Barlogie B, Alexanian R. Biology and therapy of multiple myeloma. Acta Haematol, 1987;78 Suppl 1171-4. PMID: 3124442


  1. Barlogie B, Alexanian R, Smallwood L, Cheson B, Dixon D, Dicke K, Cabanillas F. Prognostic factors with high-dose melphalan for refractory multiple myeloma. Blood, 1988 Dec;72(6);2015-9. PMID: 3196876
  2. Lee TM, Grammer LC, Shaughnessy MA. Estimation of IgE antibody with a nonisotopic technique with no interference of isotypic antibodies. J Allergy Clin Immunol, 1988 Nov;82(5 Pt 1);812-7. PMID: 3192864
  3. Quesada JR, Alexanian R, Kurzrock R, Barlogie B, Saks S, Gutterman JU. Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom’s macroglobulinemia. Am J Hematol, 1988 Sep;29(1);1-4. PMID: 3140655
  4. Alexanian R, Barlogie B, Dixon D. Prognosis of asymptomatic multiple myeloma. Arch Intern Med, 1988 Sep;148(9);1963-5. PMID: 2458080
  5. Tsuchiya H, Epstein J, Selvanayagam P, Dedman JR, Gallick G, Alexanian R, Barlogie B. Correlated flow cytometric analysis of H-ras p21 and nuclear DNA in multiple myeloma. Blood, 1988 Aug;72(2);796-800. PMID: 3042048
  6. Epstein J, Barlogie B, Katzmann J, Alexanian R. Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood, 1988 Apr;71(4);861-5. PMID: 2451550
  7. Barlogie B, Dicke KA, Alexanian R. High dose melphalan for refractory myeloma–the M.D. Anderson experience. Hematol Oncol, 1988 Apr-Jun;6(2);167-72. PMID: 3292374
  8. Barlogie B, Epstein J, Alexanian R. Genotypic and phenotypic characteristics of multiple myeloma. Hematol Oncol, 1988 Apr-Jun;6(2);99-102. PMID: 2968948
  9. Gould J, Alexanian R, Goodacre A, Pathak S, Hecht B, Barlogie B. Plasma cell karyotype in multiple myeloma. Blood, 1988 Feb;71(2);453-6. PMID: 3337907
  10. Selvanayagam P, Blick M, Narni F, van Tuinen P, Ledbetter DH, Alexanian R, Saunders GF, Barlogie B. Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. Blood, 1988 Jan;71(1);30-5. PMID: 3275475


  1. Barlogie B, Alexanian R. Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma. Cancer Res, 1989 Dec 15;49(24 Pt 1);7172-5. PMID: 2479477
  2. Barlogie B, Velasquez WS, Alexanian R, Cabanillas F. Etoposide, dexamethasone, cytarabine, and cisplatin in vincristine, doxorubicin, and dexamethasone-refractory myeloma. J Clin Oncol, 1989 Oct;7(10);1514-7. PMID: 2778481
  3. Epstein J, Xiao HQ, Oba BK. P-glycoprotein expression in plasma-cell myeloma is associated with resistance to VAD. Blood, 1989 Aug 15;74(3);913-7. PMID: 2568864
  4. Barlogie B, Smallwood L, Smith T, Alexanian R. High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma. Ann Intern Med, 1989 Apr 1;110(7);521-5. PMID: 2647015
  5. Barlogie B, Epstein J, Selvanayagam P, Alexanian R. Plasma cell myeloma–new biological insights and advances in therapy. Blood, 1989 Mar;73(4);865-79. PMID: 2465790
  6. Alexanian R, Barlogie B, Ventura G. Chemotherapy for resistant and relapsing multiple myeloma. Eur J Haematol Suppl, 1989;51140-4. PMID: 2576405
  7. Barlogie B, Alexanian R. Prognostic factors in multiple myeloma: the M.D. Anderson experience. Eur J Haematol Suppl, 1989;5184-7. PMID: 2627993